P
LIVE

Serial Number

79268126

Owner

PreciPoint Group GmbH

Attorney

Danna J. Cotman

Filing Date

Jul 12, 2019

Add to watchlist:

No watchlists yet
View on USPTO

P Trademark

Serial Number: 79268126 • Registration: 6126964

P is a trademark filed by PreciPoint Group GmbH on July 12, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

PreciPoint Group GmbH (5 trademarks)

Alois-Steinecker-Str. 22

Entity Type: 98

Trademark Details

Filing Date

July 12, 2019

Registration Date

August 18, 2020

Published for Opposition

June 2, 2020

Goods & Services

Testing apparatus not for medical purposes, namely, laboratory research apparatus for testing microscopic samples of DNA, RNA, blood, tissue and cells; distance recording apparatus; downloadable image files containing image content recorded via microscopes; biochips for research or scientific purposes; data processing apparatus; diagnostic apparatus, not for medical purposes, namely, laboratory research apparatus for analysis of microscopic samples of DNA, RNA, blood, tissue and cells; electric measuring devices, namely, measuring devices for recording DNA, RNA, blood, tissue and cell features in microscopic samples; frequency meters; computer programs, recorded, for operating digital microscopes, for digitizing of microscope slides for viewing, for processing, and for integration, management and analysis of microscopic image data; computer software, recorded, for use with digital microscopes and automated digital scan systems, in particular in the fields virtual microscopy, digital pathology, digital hematology, and medical information technology; computer programs, downloadable, for operating digital microscopes, for digitizing of microscope slides for viewing, for processing, and for integration, management and analysis of microscopic image data; computer software applications, downloadable, for use with digital microscopes and automated digital scan systems, in particular in the fields virtual microscopy, digital pathology, digital hematology, and medical information technology; interfaces for computers; laboratory trays; laboratory robots; lasers, not for medical purposes; magnifying glasses; microscopes; microtomes; microscope objectives being lenses; laboratory equipment, namely, containers for microscope slides; optical apparatus and instruments, namely, cameras; apparatus and instruments for physics, namely, lighting assemblies for microscopes; prisms for optic purposes; rearview cameras for vehicles; spectroscopes

* Magnetic resonance imaging instruments for medical purposes; apparatus for the regeneration of stem cells for medical purposes; * Apparatus for DNA and RNA testing for medical purposes; * X-rays apparatus and installations for medical purposes; * blood testing apparatus; * incubators for medical purposes; * diagnostic apparatus for medical purposes, namely, apparatus for cancer diagnosis; * electrodes for medical use; endoscopy cameras for medical purposes; medical instruments, including histopathological instruments, tissue processing apparatus and haematological instruments for clinical purposes, namely, tissue staining apparatus for stains; medical and diagnostic apparatus and instruments, namely, diagnostic medical apparatus for conducting immunohistochemical and in-situ hybridisation staining, and histological and pathological staining; medical instruments, namely, DNA in-situ hybridisation probes; diagnostic medical apparatus for promoting and controlling reactions on microarrays or beneath slides; medical instruments, needles, probes, and devices for the purpose of tissue biopsy or tissue removal from glands and organs in the human body; surgical devices, namely, vacuums for breast biopsies; biopsy location markers; X-ray, magnetic resonance, tomosynthesis, ultrasound apparatus for investigating tissue samples, namely, apparatus for preparing samples for medical diagnosis; ophthalmological apparatus and instruments, in particular refractometers, tonometers, keratometers, projection apparatus for medical purposes; systems consisting of the aforesaid apparatus and instruments; medical apparatus and instruments, in particular digital cameras, digital scanners, digital microscopic high-throughput scanners; gastroscopes; hemocytometers; body-fat monitors; * medical apparatus and instruments, namely, medical apparatus and instruments for use in diagnostic pathology; [ testing apparatus for medical purposes for testing tissue samples; apparatus for use in medical analysis, namely, apparatus for use in intra-surgical histopathologic and hematologic analysis; ] * surgical robots; pumps for medical purposes; quartz lamps for medical purposes; radiological apparatus for medical purposes; X-ray apparatus for medical purposes; X-ray photographs for medical purposes; X-ray tubes for medical purposes; radiology screens for medical purposes; radium tubes for medical purposes; * cases fitted for medical instruments; * temperature indicator labels for medical purposes; thermometers for medical purposes; tomographs for medical purposes; droppers for medical purposes; filters for ultraviolet rays, for medical purposes; ultraviolet ray lamps for medical purposes; urological apparatus and instruments; * furniture especially made for medical purposes; * temperature indicator labels for medical purposes; thermometers for medical purposes; tomographs for medical purposes; droppers for medical purposes; filters for ultraviolet rays, for medical purposes; ultraviolet ray lamps for medical purposes; urological apparatus and instruments * veterinary apparatus and instruments, namely, veterinary apparatus and instruments for use in diagnostic pathology * ; multi-well plates for use in medical research *

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 18, 2025 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
May 12, 2022 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 14, 2022 INPR
LIMITATION FROM THE IB EXAMINED AND ENTERED
May 14, 2021 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
May 14, 2021 COC.
ASSIGNED TO PARALEGAL
May 14, 2021 PLGL
LIMITATION OF GOODS RECEIVED FROM IB
May 1, 2021 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 4, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 18, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 18, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jun 12, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 27, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2020 NONP
ASSIGNED TO LIE
Apr 29, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 23, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 23, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 23, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 23, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 17, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 17, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 17, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 17, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 17, 2020 COAR
REFUSAL PROCESSED BY IB
Nov 9, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 18, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 18, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 8, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 6, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 5, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 26, 2019 REPR